Artículos de revistas
The Growing Importance Of Myelodysplastic Syndromes In Brazil [síndromes Mielodisplásicas, Sua Importância No Nosso Meio]
Registro en:
Revista Brasileira De Hematologia E Hemoterapia. , v. 28, n. 3, p. 165 - , 2006.
15168484
10.1590/S1516-84842006000300001
2-s2.0-33846907485
Autor
Lorand-Metze I.
Institución
Resumen
[No abstract available] 28 3 165
Magalhães, S.M.M., Lorand-Metze, I., Síndromes mielodisplásicas: Protocolo de exclusão (2004) Rev Bras Hematol Hemoter, 26, pp. 263-267 Lorand-Metze, L., Pinheiro, M.P., Ribeiro, E., Paula, E.V., Metze, K., Factors influencing survival in myelodysplastic syndromes in a brazilian population: Comparison of FAB and WHO classifications (2004) Leukemia Res, 28, pp. 587-594 Lorand-Metze, I., Ribeiro, E., Lima, C.S.P., Batista, L.S., Metze, K., Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders Leukemia Res, , in press Howe RB, Porwit-MacDonald A, Wanat R, Tehranchi R, Hellstrom-Lindberg E. The WHO classification of MDS does make a difference. Blood 2004;103:3.265-3. 270Malcovati, L., Germing, U., Kuendgen, A., Della Porta, M.G., Invernizzi, R., Giagounidis, A., A WHO classification-based prognostic scoring system (WPSS) for predicting survival in myelodysplastic syndromes (2005) Blood, 106, pp. 232a-233a Romeo, M., Chauffaille, M.L., Silva, M.R.R., Bahia, D.M.M., Kerbauy, J., Comparison of cytogenetics with FISH in 40 MDS patients (2002) Leuk Res, 26, pp. 993-996 Béné MC, Feuillard J, Bernard H, Maynadié M, and the GEIL. Immunophenotyping of myelodysplasia. Clin Appl Imunol Rev 2005;5:133-148Ribeiro, E., Matarraz Sudón, S., Santiago, M., Lima, C.S.P., Metze, K., Giralt, M., Maturation-associated immnophenotypic abnormalities in bone marrow B-lymphocytes in myelodysplastic syndromes (2006) Leuk Res, 30, pp. 9-16 Lorand-Metze, I., O tratamento da leucemia mielóide aguda no Brasil: O que já progredimos e o que podemos melhorar (2003) Rev Bras Hematol Hemoter, 25, pp. 1-2 Poter, J., Vichinsky, E., Rose, C., Piga, A., Olivieri, N., Gattermann, N., Phase II study with ICL 670 (Exjade@), a once- daily oral iron chelator, in patients with various transfusion-dependent anemias and iron overload (2004) Blood, 104 (SUPPL.11). , Abstract 3193 Alessandrino, E.P., Amadori, S., Barosi, G., Cazzola, M., Grossi, A., Liberato, L.N., Evidence - and consensus - based practice guidelines for the therapy of primary mielodysplastic syndromes. A statement from the Italian Society of Hematology (2002) Haematologica, 87, pp. 1.286-1.306